Expertise in
36
conditions

Dr. Michael F. Husak

Oncology
Marshfield Medical Center-Rice Lake Medical Offices-Cancer Care
1700 W Stout St, 
Rice Lake, WI 
Accepting New Patients
44 Years of Experience
Expertise in
36
conditions
Marshfield Medical Center-Rice Lake Medical Offices-Cancer Care
1700 W Stout St, 
Rice Lake, WI 

Overview

Michael Husak is an Oncologist practicing medicine in Rice Lake, Wisconsin. He has been practicing medicine for over 44 years.

Dr. Husak is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Pleuropulmonary Blastoma, Lung Cancer, Inflammatory Breast Cancer, and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 9 clinical trials. Dr. Husak is currently accepting new patients.

Graduate Year

1982

Specialties

Oncology

Licenses

Internal Medicine in WI

Hospital Affiliations

Tamarack Health Hayward Medical Center
Marshfield Medical Center - Rice Lake
Marshfield Medical Center
Marshfield Medical Center - Ladysmith
Marshfield Medical Center - Eau Claire

Languages Spoken

English
German
Italian

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
HealthPartners
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Security Health
  • EPO
  • HMO
  • INDEMNITY
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Marshfield Medical Center-Rice Lake Medical Offices-Cancer Care
1700 W Stout St, Rice Lake, WI 54868

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

RAndomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial
RAndomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial
Enrollment Status: Suspended
Publish Date: September 04, 2026
Intervention Type: Procedure, Radiation, Drug
Study Drug: Atezolizumab
Study Phase: Phase 2/Phase 3
A Randomized Phase III Study of Immune Checkpoint Inhibition With Chemotherapy in Treatment-Naive Metastatic Anal Cancer Patients
A Randomized Phase III Study of Immune Checkpoint Inhibition With Chemotherapy in Treatment-Naive Metastatic Anal Cancer Patients
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Biological, Drug
Study Drugs: Carboplatin, Nivolumab, Paclitaxel
Study Phase: Phase 3
Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Cisplatin, Fluorouracil, Gemcitabine Hydrochloride, Paclitaxel
Study Phase: Phase 2/Phase 3
Phase II Trial of Intravesical Gemcitabine and MK-3475 (Pembrolizumab) in the Treatment of Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Phase II Trial of Intravesical Gemcitabine and MK-3475 (Pembrolizumab) in the Treatment of Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 11, 2026
Intervention Type: Procedure, Drug, Biological
Study Drugs: Gemcitabine Hydrochloride, Pembrolizumab
Study Phase: Phase 2
A Phase II Randomized Study of Adjuvant Versus NeoAdjuvant Pembrolizumab (MK-3475) for Clinically Detectable Stage III-IV High-Risk Melanoma
A Phase II Randomized Study of Adjuvant Versus NeoAdjuvant Pembrolizumab (MK-3475) for Clinically Detectable Stage III-IV High-Risk Melanoma
Enrollment Status: Active_not_recruiting
Publish Date: August 04, 2026
Intervention Type: Procedure, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 2
Randomized Phase II/III Study of Venetoclax (ABT199) Plus Chemoimmunotherapy for MYC/BCL2 Double-Hit and Double Expressing Lymphomas
Randomized Phase II/III Study of Venetoclax (ABT199) Plus Chemoimmunotherapy for MYC/BCL2 Double-Hit and Double Expressing Lymphomas
Enrollment Status: Active_not_recruiting
Publish Date: August 04, 2026
Intervention Type: Drug, Biological, Procedure
Study Drugs: Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide, Prednisone, Rituximab, Venetoclax, Vincristine Sulfate
Study Phase: Phase 2/Phase 3
A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer
A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 04, 2026
Intervention Type: Other, Procedure, Drug
Study Drugs: Entinostat, Exemestane, Goserelin, Goserelin Acetate
Study Phase: Phase 3
A Randomized Phase II Trial of Carboplatin-Paclitaxel With or Without Ramucirumab in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic Thymic Carcinoma
A Randomized Phase II Trial of Carboplatin-Paclitaxel With or Without Ramucirumab in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic Thymic Carcinoma
Enrollment Status: Completed
Publish Date: October 30, 2025
Intervention Type: Drug, Biological
Study Drugs: Carboplatin, Paclitaxel, Ramucirumab
Study Phase: Phase 2
Phase III Placebo-Controlled Trial to Evaluate Dexamethasone Use for Everolimus-Induced Oral Stomatitis: Prevention Versus Early Treatment Approaches: MIST (My Individualized Stomatitis Treatment)
Phase III Placebo-Controlled Trial to Evaluate Dexamethasone Use for Everolimus-Induced Oral Stomatitis: Prevention Versus Early Treatment Approaches: MIST (My Individualized Stomatitis Treatment)
Enrollment Status: Terminated
Publish Date: January 29, 2025
Intervention Type: Other, Drug
Study Phase: Phase 3
View 8 Less Clinical Trials

2 Total Publications

Severe Thrombocytopenia Secondary to Babesiosis: A Case Report.
Severe Thrombocytopenia Secondary to Babesiosis: A Case Report.
Journal: Case reports in hematology
Published: February 14, 2024
Similar Doctors
Expertise in
43
conditions
Expertise in
43
conditions
Referral may be required

Mayo Clinic Health System

1221 Whipple St, 
Eau Claire, WI 
 (49.5 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Scott Okuno is an Oncologist practicing medicine in Eau Claire, Wisconsin. Dr. Okuno is highly rated in 43 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Angiosarcoma, and Alveolar Soft Part Sarcoma. Dr. Okuno is currently accepting new patients.

Expertise in
29
conditions
Expertise in
29
conditions
Referral may be required

Marshfield Medical Center-Rice Lake Medical Offices-Cancer Care

1700 W Stout St, 
Rice Lake, WI 
 (0.1 miles away)
715-236-8235
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients

Kareem Abdelhadi is an Oncologist practicing medicine in Rice Lake, Wisconsin. Dr. Abdelhadi is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Inflammatory Breast Cancer, Familial Colorectal Cancer, Paget Disease of the Breast, and Colorectal Cancer. Dr. Abdelhadi is currently accepting new patients.

Expertise in
25
conditions
Expertise in
25
conditions
Referral may be required

Marshfield Medical Center-Eau Claire Cancer Center

2200 Craig Rd, 
Eau Claire, WI 
 (50.5 miles away)
715-858-6767
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dean Delmastro is an Oncologist practicing medicine in Eau Claire, Wisconsin. Dr. Delmastro is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Hemangioma Thrombocytopenia Syndrome, Inflammatory Breast Cancer, and Pleuropulmonary Blastoma. Dr. Delmastro is currently accepting new patients.

Frequently Asked Questions about Dr. Michael F. Husak

How do I make an appointment with Dr. Michael F. Husak?

You can book an appointment with Dr. Michael F. Husak by calling their office at 715-236-8235. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Michael F. Husak a top-rated expert for Familial Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michael F. Husak is classified as an Distinguished expert for Familial Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Michael F. Husak specialize in?

While Dr. Michael F. Husak is a Oncology, they have specific expertise in Familial Colorectal Cancer, Pleuropulmonary Blastoma, and Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Michael F. Husak participate in research or clinical trials?

Yes. Dr. Michael F. Husak has published 2 articles and abstracts on conditions like Familial Colorectal Cancer. You can view a list of Dr. Michael F. Husak's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Michael F. Husak accept my insurance?

Dr. Michael F. Husak accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 715-236-8235 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Husak's expertise for a condition
ConditionClose
    View All 32 Advanced Conditions
    View All 91 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile